Zobrazeno 1 - 10
of 640
pro vyhledávání: '"William C, Cushman"'
Autor:
Yizhe Xu, Catherine G. Derington, Daniel K. Addo, Tao He, Joshua A. Jacobs, April F. Mohanty, Jaejin An, William C. Cushman, P. Michael Ho, Brandon K. Bellows, Jordana B. Cohen, Adam P. Bress
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 20 (2024)
Background Among patients diagnosed with high blood pressure (BP), initial dual therapy has been recommended for patients with high pretreatment systolic BP (≥160 mm Hg) since 2003, and first‐line β‐blocker use without a compelling condition h
Externí odkaz:
https://doaj.org/article/e25fb27abb434995bd67a0100bb57976
Autor:
Hertzel C. Gerstein, Chinthanie Ramasundarahettige, Alvero Avezum, Jan Basile, Ignacio Conget, William C. Cushman, Gilles R. Dagenais, Edward Franek, Mark Lakshmanan, Fernando Lanas, Lawrence A. Leiter, Nana Pogosova, Jeffrey Probstfield, Peter J. Raubenheimer, Matthew Riddle, Jonathan Shaw, Wayne H.-H. Sheu, Theodora Temelkova-Kurktschiev, Ibrahim Turfanda, Denis Xavier
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-8 (2022)
Abstract Background The estimated glomerular filtration rate (eGFR) and the albumin-to-creatinine ratio (ACR) are risk factors for diabetes-related outcomes. A composite that captures information from both may provide a simpler way of assessing risk.
Externí odkaz:
https://doaj.org/article/d7e83d72a5384fcfbe6664e1096dbb38
Autor:
Catherine G. Derington, Adam P. Bress, Jennifer S. Herrick, Joshua A. Jacobs, Alexander R. Zheutlin, Ransmond O. Berchie, Molly B. Conroy, William C. Cushman, Jordan B. King
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 11 (2023)
Background Fixed‐dose combination (FDC) antihypertensive products improve blood pressure control and adherence among patients with hypertension. It is unknown to what degree commercially available FDC products meet the current hypertension manageme
Externí odkaz:
https://doaj.org/article/a272e666eb7748f593b25f30788b8455
Autor:
Xiaobei Dong, Chi Chun Steve Tsang, Jamie A. Browning, Joseph Garuccio, Jim Y. Wan, Ya Chen Tina Shih, Marie A. Chisholm-Burns, Samuel Dagogo-Jack, William C. Cushman, Junling Wang
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 9, Iss , Pp 100222- (2023)
Background: The Medicare Part D medication therapy management (MTM) program has positive effects on medication and health service utilization. However, little is known about its utilization, much less so about the use among racial and ethnic minoriti
Externí odkaz:
https://doaj.org/article/b79eead49dcb415993afa5048d9ba9be
Autor:
Xiaobei Dong, Chi Chun Steve Tsang, Jim Y. Wan, Ya-Chen Tina Shih, Marie A. Chisholm-Burns, Samuel Dagogo-Jack, William C. Cushman, Lisa E. Hines, Junling Wang
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 3, Iss , Pp 100041- (2021)
Background: There has been a lack of evidence on whether there are racial and ethnic disparities in medication nonadherence among individuals receiving comprehensive medication review (CMR), a required component of the Medicare Part D medication ther
Externí odkaz:
https://doaj.org/article/7bfeac3f98fd4301b59bfcb4d47d6869
Autor:
Xiaobei Dong, Chi Chun Steve Tsang, Jamie A. Browning, Yongbo Sim, Jim Y. Wan, Marie A. Chisholm-Burns, Samuel Dagogo-Jack, William C. Cushman, Junling Wang
Publikováno v:
Current Medical Research and Opinion. :1-15
Autor:
Chi Chun Steve, Tsang, Ya-Chen Tina, Shih, Xiaobei, Dong, Joseph, Garuccio, Jamie A, Browning, Jim Y, Wan, Marie A, Chisholm-Burns, Samuel, Dagogo-Jack, William C, Cushman, Rose, Zeng, Junling, Wang
Publikováno v:
Value in Health. 26:649-657
Equity and effectiveness of the medication therapy management (MTM) program in Medicare has been a policy focus since its inception. The objective of this study was to evaluate the cost-effectiveness of the Medicare MTM program in improving medicatio
Autor:
Brandon K. Bellows, Yiyi Zhang, Zugui Zhang, Donald M. Lloyd‐Jones, Adam P. Bress, Jordan B. King, Paul Kolm, William C. Cushman, Karen C. Johnson, Leonardo Tamariz, Elizabeth C. Oelsner, Steven Shea, Anne B. Newman, Diane G. Ives, David Couper, Andrew E. Moran, William S. Weintraub
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 10 (2021)
Background Intensive systolic blood pressure treatment (
Externí odkaz:
https://doaj.org/article/294866d88a554e499559e160192d71b9
Autor:
Kelley R.H. Branch, Gilles R. Dagenais, Alvaro Avezum, Jan Basile, Ignacio Conget, William C. Cushman, Petr Jansky, Mark Lakshmanan, Fernando Lanas, Lawrence A. Leiter, Prem Pais, Nana Pogosova, Peter J. Raubenheimer, Lars Ryden, Jonathan E. Shaw, Wayne H.H. Sheu, Theodora Temelkova‐Kurktschiev, M. Angelyn Bethel, Hertzel C. Gerstein, Ramasundarahettige Chinthanie, Jeffrey L. Probstfield
Publikováno v:
European Journal of Heart Failure. 24:1805-1812
Autor:
William C, Cushman, Robert J, Ringer, Carlos J, Rodriguez, Gregory W, Evans, Jeffrey T, Bates, Jeffrey A, Cutler, Amret, Hawfield, Dalane W, Kitzman, Ilya M, Nasrallah, Suzanne, Oparil, John, Nord, Vasilios, Papademetriou, Karen, Servilla, Peter, Van Buren, Paul K, Whelton, Jeff, Whittle, Jackson T, Wright
Publikováno v:
Hypertension. 79:2071-2080
Background: The SPRINT (Systolic Blood Pressure Intervention Trial) demonstrated reductions in major cardiovascular disease events and mortality with an intensive systolic blood pressure (SBP) goal intervention. However, a detailed description of the